MAGNETIC  HYPERTHERMIA FOR CANCER TREATMENT : SYNTHESIS OF NANOPARTICLES FOR THERMO-CHEMOTHERAPY

Nikhil J. Waghmare; Mr.Sangmesh N Yewangea; Mr.Harangule Yogesh R; NANDKISHOR B. BAVAGE; VIDYASAGAR GALIB; SHYAMLILA B. BAVAGE

MAGNETIC HYPERTHERMIA FOR CANCER TREATMENT : SYNTHESIS OF NANOPARTICLES FOR THERMO-CHEMOTHERAPY

Authors: Nikhil J. Waghmare, Mr.Sangmesh N Yewangea , Mr.Harangule Yogesh R , NANDKISHOR B. BAVAGE, VIDYASAGAR GALIB, SHYAMLILA B. BAVAGE

Unique Paper ID: 149272
Volume: 6
Issue: 11
PageNo: 496-501

Keywords: Magnetic nanoparticle hyperthermia cancer tumor

Abstract:
Hyperthermia therapy is a type of medical treatment in which body tissue is exposed to higher temperatures in an effort to treat Lyme disease and cancer.[1] Hyperthermia uses higher temperatures than diathermy, which is the deep heating of body tissue for relaxation or physical therapy. Techniques that bring local tissues to quite high temperatures, such as radio frequency ablation, are also not usually included in "hyperthermia".[2] When combined with radiation therapy, it is called thermoradiotherapy. Hyperthermia is defined as supra-normal body temperatures. There is no consensus as to what is the safest or most effective target temperature for the whole body. During treatment the body temperature reaches a level between 39.5 and 40.5 Â°C (103.1 and 104.9 Â°F).[3] However, other researchers define hyperthermia between 41.8â€“42 Â°C (107.2â€“107.6 Â°F) (Europe, USA) to near 43â€“44 Â°C (109â€“111 Â°F) (Japan, Russia).[4]

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 6
Issue: 11
PageNo: 496-501

MAGNETIC HYPERTHERMIA FOR CANCER TREATMENT : SYNTHESIS OF NANOPARTICLES FOR THERMO-CHEMOTHERAPY

Available:https://ijirt.org/Article?manuscript=149272

11 Jan, 2022

EVALUATION OF MARKETED EFFERVESCENT TABLETS

13 Oct, 2021

Bacterial Biofilm Inhibitor

02 Aug, 2021

The risk of death caused by the use of norepinephrine-resistant hypotension in the condition of septic shock in a patient

02 Aug, 2021

COMPUTER AIDED DRUG DESIGN (CADD)

29 Jul, 2021

Impact : Of Second Wave Covid-19 In world

29 Jul, 2021

The use of milrinone for curing a chronic heart failure

26 Jul, 2021

Leprosy Disease review

20 Jul, 2021

Transdermal Drug Delivery System

13 Jul, 2021

IBUPROFEN: AN OVERVIEW

13 Jul, 2021

CHEMOTHERAPY FOR BREAST CANCER

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry